Puma's Neratinib SUMMIT Study Shows Potential & Pitfalls Of Precision Medicine

"Basket trial" design allowed Puma to identify certain cohorts for further study, but also missed in areas where neratinib was expected to work.

More from Clinical Trials

More from R&D